×

$9.5 billion blockbuster drug deal

1:01 PM ET Mon, 8 Dec 2014

Following Merck's acquisition of Cubist, chairman and CEO Kenneth Frazier discusses innovation possibilities the deal presents for public health, with CNBC's Meg Tirrell.